Rapid blood cell recovery with immunosuppressive therapy combined with romiplostim in a patient with very severe hepatitis-associated aplastic anemia who underwent liver transplantation

We present the case of a child with severe HAA who underwent LDLT, and who achieved rapid blood cell recovery with IST combined with romiplostim, a thrombopoietin receptor agonist. In addition, despite having undergone LDLT, the patient had no adverse events such as serious liver dysfunction or thrombosis. This case suggests that IST combined with thrombopoietin receptor agonists may be a promising treatment option for HAA patients undergoing LDLT.PMID:34110619 | DOI:10.1007/s12185-021-03165-z

Source: International Journal of Hematology - June 10, 2021 Category: Hematology Authors: Hiroki Yoshinari Yuta Kawahara Hitomi Niijima Yukiko Oh Yuta Hirata Noriki Okada Yukihiro Sanada Yasuharu Onishi Yasunaru Sakuma Akira Morimoto Source Type: research